Please login to the form below
safety
This page shows the latest safety news and features for those working in and with pharma, biotech and healthcare.
Biogen’s Vumerity recommended by CHMP in MS
The CHMP positive opinion is based on the well-established long-term safety and efficacy profile of Tecfidera plus data from pharmacokinetic bridging studies comparing the two drugs.
Latest news
-
Valneva shares fall as UK cancels COVID-19 vaccine order
The agreement allows the UK government to terminate the contract early in a relatively wide range of circumstances including safety issues, lack of efficacy or a breakdown in supply as well
-
Behaviour change theory
Mead. “Behaviour change takes time. For instance, the campaign to promote seat belt safety in the UK took years of consistent communication before the desired behaviour became the norm.
-
AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
Real-world data shows similar safety profile for Vaxzevria and mRNA-based jabs. ... According to AZ, the safety profiles of Vaxzevria and the undisclosed were similar and ‘overall favourable’, with cases of TTS disorders observed with both vaccines.
-
Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
FDA) review into the safety data from a post-marketing study of the therapy.
-
AbbVie reveals new data for presbyopia eye drop treatment
The new data includes full results from the phase 3 GEMINI 1 clinical trial, evaluating the efficacy and safety of AGN-190584 (pilocarpine 1.25%) for presbyopia. ... We are pleased with the favourable safety and efficacy results, as well as the rapid
Valneva shares fall as UK cancels COVID-19 vaccine order
Behaviour change theory
AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
AbbVie reveals new data for presbyopia eye drop treatment
More from news
Approximately 86 fully matching, plus 2,372 partially matching documents found.
Latest Intelligence
-
Recruiting patients for real-world studies – the power of a digital campaign
Research conducted outside randomised controlled trials (RCTs) can be used to monitor patient safety and measure drug utilisation.
-
The future of work has been just around the corner for some time...
Turned engagement into an addiction: building on strong psychological safety and trust, we communicated authentically, stayed together virtually, encouraged humanised check-ins and had fun together. ... Finally, psychological and physical safety will
-
Pre-launch planning and DSLs – the new ways to create launch excellence in pharma
Further topics that they might discuss regarding your drug candidate could be the study and drug trial data, safety and effectiveness, customer experience or general education and information. ... efficacy, safety, pricing, medicine administration). Test
-
Pharma’s authentic proof of purpose influences decisions among HCPs and payers
We looked at whether a company’s perceived purpose affects the decision-making process of HCPs and payers, especially when faced with otherwise parity (in terms of price, efficacy and safety).
-
How early-stage clinical research is facilitating the new wave of personalised medicines
It is important that physicians seek to develop more advanced and specialist skills via such schemes to ensure the safety of patients in the development of new gene therapies and other
Recruiting patients for real-world studies – the power of a digital campaign
The future of work has been just around the corner for some time...
Pre-launch planning and DSLs – the new ways to create launch excellence in pharma
Pharma’s authentic proof of purpose influences decisions among HCPs and payers
How early-stage clinical research is facilitating the new wave of personalised medicines
More from intelligence
Approximately 2 fully matching, plus 214 partially matching documents found.
Latest appointments
-
New hires at Bristol-Myers Squibb, Acceleron and FerGene
Prior to Celgene, he served as vice president, global medical affairs and safety at Pharmion.
-
BMS appoints new commercial leader, Davies joins Eisai and more
Officially joining the biopharma on 1 October, Schuermans will play a part in bringing together Sobi’s manufacturing operations/biological development and supply, quality, supply chain, procurement and environment and safety
-
Immodulon Therapeutics bolsters senior team
clinical research, medical affairs and drug safety.
-
Prof Sir Mike Richards joins Incisive Health as senior counsel
In his most recent role Sir Mike led the inspection, quality and safety agenda for hospitals and prior to that he served in senior clinical roles at NHS England and the
-
Eli Lilly appoints senior VP for corporate affairs and communications
Institute for Highway Safety.
New hires at Bristol-Myers Squibb, Acceleron and FerGene
BMS appoints new commercial leader, Davies joins Eisai and more
Immodulon Therapeutics bolsters senior team
Prof Sir Mike Richards joins Incisive Health as senior counsel
Eli Lilly appoints senior VP for corporate affairs and communications
More from appointments
Approximately 0 fully matching, plus 50 partially matching documents found.
Latest from PMHub
-
Health literacy in the time of COVID-19
The most important determinants of COVID-19 vaccine hesitancy were distrust of the vaccine safety and general vaccine avoidance, as implied by not having had a flu shot in the last
-
#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
Cultural safety training allows people to be introspective, to evaluate how their own cultural identity can impact their interactions with patients. ... Cultural safety training can help to improve the diversity in clinical trials, as well as the
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
22, 23. Public trust in their government, science, and the safety of vaccination. ... 25. Co-creator of AstraZeneca COVID shot defends safety amid clot concerns.Reuters.
-
How do ethnic minority groups in the U.S. view clinical trials?
Some participants described the need for cultural safety training among healthcare professionals.
-
Addressing the Gendered Health Data Gap
temperature of your office and the safety specifications of your car.
#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
How do ethnic minority groups in the U.S. view clinical trials?
Addressing the Gendered Health Data Gap
More from PMHub
Approximately 4 fully matching, plus 123 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- EU “still interested” in Valneva COVID vaccine despite UK snub
- US demand for COVID-19 antibody treatments rising fast
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- Advancing Drug Discovery with Structured and Intelligent Data
- Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
- Gilead’s Veklury (remdesivir) cuts risk of severe COVID-19 by 87%
- Amgen’s Biosimilar Trends Report shows benefit of competition from biosimilars
- Cuttsy+Cuttsy awarded Gold accreditation by Investors in People
- Nudging someone in the right direction isn’t always easy – that’s where behavioural science comes in
No results were found
PMHub
McCann Health Medical Communications
We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....
Latest intelligence
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
